Bezisterim

Intervention1 paper2 findings

Human trial1

Outcomes

2

Insulin resistance

downin humans1

1 study

Bezisterim decreases insulin resistance in humans.
Review
Bezisterim Treatment Is Associated with Changes in DNA Promoter Methylation Linked to Epigenetic Aging, Metabolic Risk, and Neurodegenerative Pathways · ADA Scientific Sessions 2026 abstract · 5 Jun 2026

Epigenetic age

downin humans1Moderate certainty

1 study

Bezisterim decreases epigenetic age in humans.
Human trialin mild-to-moderate AD
Bezisterim Treatment Is Associated with Changes in DNA Promoter Methylation Linked to Epigenetic Aging, Metabolic Risk, and Neurodegenerative Pathways · ADA Scientific Sessions 2026 abstract · 5 Jun 2026

Epigenetic age →

Latest

1

ADA Scientific Sessions 2026 AbstractHuman trial5 Jun

Bezisterim Treatment Is Associated with Changes in DNA Promoter Methylation Linked to Epigenetic Aging, Metabolic Risk, and Neurodegenerative Pathways